Compare DRUG & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRUG | BBW |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.1M | 629.9M |
| IPO Year | 2020 | 2004 |
| Metric | DRUG | BBW |
|---|---|---|
| Price | $72.00 | $40.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $124.00 | $67.71 |
| AVG Volume (30 Days) | 86.7K | ★ 445.2K |
| Earning Date | 05-15-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | N/A | ★ 4.11 |
| EPS | N/A | ★ 2.73 |
| Revenue | N/A | ★ $357,866,000.00 |
| Revenue This Year | N/A | $5.60 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ N/A | $14.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.18 | $32.55 |
| 52 Week High | $123.75 | $75.77 |
| Indicator | DRUG | BBW |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 34.01 |
| Support Level | $71.04 | N/A |
| Resistance Level | $84.29 | $55.69 |
| Average True Range (ATR) | 3.99 | 2.54 |
| MACD | -0.82 | 0.01 |
| Stochastic Oscillator | 14.20 | 26.37 |
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.